CasNo.1231930-82-7,LY2835219,(1231930-82-7) Suppliers

0 Metric Ton	Negotiable

Min.Order :0 Metric Ton
Purity: 98% min

Keywords

LY2835219 ABEMACICLIB; CDK4/6 dual inhibitor; LY 2835219; LY-2835219 1231930-82-7

Quick Details

Appearance:
Application:
PackAge:5mg;10mg;50mg;
ProductionCapacity:50-100|Metric Ton|Day
Storage:-20℃
Transportation:

Superiority:

LY2835219LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM, respectively. IC50 Value: 2 nM(CDK4); 10 nM(CDK6) Target: CDK4/6 in vitro: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

url：www.medchemexpress.cn/ly2835219.html

Details:

LY2835219LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM, respectively. IC50 Value: 2 nM(CDK4); 10 nM(CDK6) Target: CDK4/6 in vitro: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

url：www.medchemexpress.cn/ly2835219.html